XML 26 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
Note 4 - Earnings Per Common Share
3 Months Ended
Sep. 30, 2022
Notes to Financial Statements  
Earnings Per Share [Text Block]

NOTE 4 - EARNINGS PER COMMON SHARE

 

The following table presents the amounts used to compute basic and diluted earnings per common share, as well as the effect of dilutive potential common shares on weighted average shares outstanding (in thousands, except per share data):

 

   

Three Months Ended

 
   

September 30

 
   

2022

   

2021

 
                 

BASIC EARNINGS PER SHARE

               
                 

Net income

  $ 6,262     $ 3,133  
                 

Weighted average shares outstanding during the period, net of treasury shares

    26,730       26,553  

Weighted average vested restricted stock units outstanding

    46       17  

Weighted average shares outstanding in the Deferred Compensation Plan during the period

    865       426  

Weighted average shares outstanding

    27,641       26,996  
                 

Basic earnings per common share

  $ 0.23     $ 0.12  
                 
                 

DILUTED EARNINGS PER SHARE

               
                 

Net income

  $ 6,262     $ 3,133  
                 
Weighted average shares outstanding:                
                 

Basic

    27,641       26,996  
                 

Effect of dilutive securities (a):

               

Impact of common shares to be issued under stock option plans, and contingently issuable shares, if any

    1,023       747  

Weighted average shares outstanding

    28,664       27,743  
                 

Diluted earnings per common share

  $ 0.22     $ 0.11  
                 
                 

Anti-dilutive securities (b)

    213       989  

 

 

 

(a)

Calculated using the “Treasury Stock” method as if dilutive securities were exercised and the funds were used to purchase common shares at the average market price during the period.

 

 

(b)

Anti-dilutive securities were excluded from the computation of diluted net income per share for the three months ended September 30, 2022, and September 30, 2021, because the exercise price was greater than the average fair market price of the common shares or because the assumed proceeds from the award’s exercise or vesting was greater than the average fair market price of the common shares.